Using structural equation model to illustrate the relationship between metabolic risk factors and cardiovascular complications in Taiwan

European Journal of Preventive Cardiology

Volumn 13, Issue 4, 2006, Pages 633-639

  Lin, Jou Wei ^a   Hwang, Juey Jen ^a   Dai, Dao fu ^a   Tseng, Yung zu ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

atherosclerosis; diabetes mellitus; metabolic syndrome X; statistical models; TTaiwan

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SCREENING TEST; SEX RATIO; STATISTICAL ANALYSIS; STATISTICAL MODEL; STRUCTURAL EQUATION MODELING; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

ADULT; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MODELS, STATISTICAL; MYOCARDIAL ISCHEMIA; ODDS RATIO; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; SEX DISTRIBUTION; STROKE; TAIWAN;

EID: 33746743071     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000230095.65062.a9     Document Type: Article

References (33)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, II: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.
2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: WHO; 1999 (WHO/NCD/NCS 99.2).
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
4. Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary arteriosclerosis. Circulation 2004; 110: 803–809.
5. Grandinetti A, Chang HK, Theriault A, Mor J. Metabolic syndrome in a multiethnic population in rural Hawaii Ethnic Dis 2005; 15: 233–237.
6. Chuang SY, Chen CH, Chou P. Prevalence of metabolic syndrome in a large health check-up population in Taiwan. J Chin Med Assoc 2004; 67: 611–620.
7. Boyko EJ, Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. Feature of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care 2000; 23: 1242–1248.
8. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, et al Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003; 26: 1251–1257.
9. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245–1250.
10. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National cholesterol education program versus world health organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004; 110: 1251–1257.
11. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 385–390.
12. Sanchih Household Registrator Office. Population registry. 2005. Available at: http://www.sanchih.tpc.gov.tw/default.htm. Accessed: 19 February 2006.
13. The National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.
15. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf. Accessed: 19 February 2006.
16. Department of Health, Taiwan. The definition and management of obesity in Taiwanese people, 2005. Available at: http://www.doh.gov.tw/cht/content.aspx. Accessed: 19 February 2006.
17. Adler AI, Stratton IM, Nei AW, Yudkin JS, Matthews DR, and UKPDS Group. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412–419.
18. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al Blood pressure, stroke, and coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774.
19. The Ministry of the Interior, Taiwan, 2005. Available at: http://www.ris.gov.tw/ch4/static/st20-0.html. Accessed: 19 February 2006.
20. Chuang SY, Chen CH, Tsai ST, Chou P. Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiol Sin 2002; 18: 16–23.
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.
22. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575–581.
23. Sheu WH. The metabolic syndrome: what have we learned? [Editorial]. J Chin Med Assoc 2004; 67: 597–599.
24. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al The metabolic syndrome and total and cardiovascular diseases mortality in middle-aged men. JAMA 2002; 288: 2709–2716.
25. Edo A. Aging, telomers, and atherosclerosis. Cardiovasc Res 2005; 66: 213–221.
26. Mota M, Panus C, Mota E, Lichiardopol C, Vladu D, Toma E. The metabolic syndrome - a multifaced disease. Rom J Intern Med 2004; 42: 247–255.
27. Li S, Chen W, Srinivasan SR, Berenson GS. Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: the Bogalusa Heart Study. Atherosclerosis 2005; 180: 349–354.
28. Yarnell JWG. Smoking and cardiovascular disease. QJM 1996; 89: 493–498.
29. Dzien A, Dzien-Bischinger C, Hoppichler F, Lechleitner M. The metabolic syndrome as a link between smoking and cardiovascular disease. Diabet Obes Metab 2004; 6: 127–132.
30. Mack R, Skurnick B, Sterling-Jean Y, Pedra-Nobre M, Bigg D. Fasting insulin levels as a measure of insulin resistance in American blacks. J Appl Res 2004; 4: 90–94.
31. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, et al Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome - nested case-control study. Circulation 2002; 106: 2659–2665.
32. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and the prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 10: 380–385.
33. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000; 152: 897–907.